Several studies included NT-proBNP levels in the development of risk scores to predict in-hospital mortality in patients with HF [25,28,29] or as a risk stratification tool for acute exacerbations in patients with COPD [30]. The gene discussed is NPPB; the disease is chronic obstructive pulmonary disease.